These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 28957562)

  • 21. Reducing the burden of surveillance in pregnant women with no history of fetal atrioventricular block using the negative predictive value of anti-Ro/SSA antibody titers.
    Kaizer AM; Lindblade C; Clancy R; Tebo AE; Drewes B; Masson M; Chang M; Fraser N; Buyon JP; Cuneo BF
    Am J Obstet Gynecol; 2022 Nov; 227(5):761.e1-761.e10. PubMed ID: 35690080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progression to first-degree heart block in preschool children exposed in utero to maternal anti-SSA/Ro52 autoantibodies.
    Bergman G; Eliasson H; Mohlkert LA; Wahren-Herlenius M; Sonesson SE
    Acta Paediatr; 2012 May; 101(5):488-93. PubMed ID: 22175870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-Ro/SSA autoantibody-positive women's experience of information given on the risk of congenital heart block.
    Tingström J; Hjelmstedt A; Welin Henriksson E; Ambrosi A; Sonesson SE; Wahren-Herlenius M
    Lupus; 2016 Apr; 25(5):536-42. PubMed ID: 26670329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ro/SSA autoantibody-positive pregnancy: reactions to serial fetal Doppler echocardiographic surveillance.
    Tingström J; Hjelmstedt A; Welin Henriksson E; Sonesson SE; Wahren-Herlenius M
    Lupus; 2015 Dec; 24(14):1540-5. PubMed ID: 26113358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fetal atrioventricular interval measurement: technical aspects].
    Journet D; Bienstman J; Joly H; Rudigoz RC; Huissoud C
    J Gynecol Obstet Biol Reprod (Paris); 2011 Oct; 40(6):580-5. PubMed ID: 21880439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Congenital heart block: evidence for a pathogenic role of maternal autoantibodies.
    Ambrosi A; Wahren-Herlenius M
    Arthritis Res Ther; 2012 Apr; 14(2):208. PubMed ID: 22546326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases--a multicentre prospective study.
    Gerosa M; Cimaz R; Stramba-Badiale M; Goulene K; Meregalli E; Trespidi L; Acaia B; Cattaneo R; Tincani A; Motta M; Doria A; Zulian F; Milanesi O; Brucato A; Riboldi P; Meroni PL
    Rheumatology (Oxford); 2007 Aug; 46(8):1285-9. PubMed ID: 17449486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block. An Italian multicentre cross-sectional study on behalf of the 'Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group'.
    Scarsi M; Radice A; Pregnolato F; Ramoni V; Grava C; Bianchi L; Gerosa M; Mosca M; Ghirardello A; Tani C; Motta M; Quinzanini M; Tincani A; Ruffatti A; Migliorini P; Doria A; Meroni PL; Brucato A
    Clin Exp Rheumatol; 2014; 32(6):848-54. PubMed ID: 25327946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolongation of the atrioventricular conduction in fetuses exposed to maternal anti-Ro/SSA and anti-La/SSB antibodies did not predict progressive heart block. A prospective observational study on the effects of maternal antibodies on 165 fetuses.
    Jaeggi ET; Silverman ED; Laskin C; Kingdom J; Golding F; Weber R
    J Am Coll Cardiol; 2011 Mar; 57(13):1487-92. PubMed ID: 21435519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal sonographic monitoring of progressive cardiac damages caused by anti-Ro antibodies: A case report.
    Tongprasert F; Sittiwangkul R; Lerthiranwong T; Tongsong T
    J Clin Ultrasound; 2018 Jun; 46(5):347-350. PubMed ID: 29023775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-Ro52 monoclonal antibodies specific for amino acid 200-239, but not other Ro52 epitopes, induce congenital heart block in a rat model.
    Ambrosi A; Dzikaite V; Park J; Strandberg L; Kuchroo VK; Herlenius E; Wahren-Herlenius M
    Ann Rheum Dis; 2012 Mar; 71(3):448-54. PubMed ID: 22084395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants.
    Jaeggi E; Laskin C; Hamilton R; Kingdom J; Silverman E
    J Am Coll Cardiol; 2010 Jun; 55(24):2778-84. PubMed ID: 20538173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conduction system disease in fetuses evaluated for irregular cardiac rhythm.
    Cuneo BF; Strasburger JF; Wakai RT; Ovadia M
    Fetal Diagn Ther; 2006; 21(3):307-13. PubMed ID: 16601344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fetal Doppler echocardiographic diagnosis and successful steroid therapy of Luciani-Wenckebach phenomenon and endocardial fibroelastosis related to maternal anti-Ro and anti-La antibodies.
    Raboisson MJ; Fouron JC; Sonesson SE; Nyman M; Proulx F; Gamache S
    J Am Soc Echocardiogr; 2005 Apr; 18(4):375-80. PubMed ID: 15846168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers.
    Izmirly P; Kim M; Friedman DM; Costedoat-Chalumeau N; Clancy R; Copel JA; Phoon CKL; Cuneo BF; Cohen RE; Robins K; Masson M; Wainwright BJ; Zahr N; Saxena A; Buyon JP
    J Am Coll Cardiol; 2020 Jul; 76(3):292-302. PubMed ID: 32674792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular and ionic basis of congenital complete heart block.
    Boutjdir M
    Trends Cardiovasc Med; 2000 Apr; 10(3):114-22. PubMed ID: 11427998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactivity to the p305 Epitope of the α1G T-Type Calcium Channel and Autoimmune-Associated Congenital Heart Block.
    Markham AJ; Rasmussen SE; Salmon JE; Martinez-Ortiz W; Cardozo TJ; Clancy RM; Buyon JP
    J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25994441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies.
    Askanase AD; Friedman DM; Copel J; Dische MR; Dubin A; Starc TJ; Katholi MC; Buyon JP
    Lupus; 2002; 11(3):145-51. PubMed ID: 11999879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies to amino acid 200-239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block.
    Strandberg L; Winqvist O; Sonesson SE; Mohseni S; Salomonsson S; Bremme K; Buyon JP; Julkunen H; Wahren-Herlenius M
    Clin Exp Immunol; 2008 Oct; 154(1):30-7. PubMed ID: 18727629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects.
    Clancy RM; Buyon JP; Ikeda K; Nozawa K; Argyle DA; Friedman DM; Chan EK
    Arthritis Rheum; 2005 Oct; 52(10):3079-86. PubMed ID: 16200587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.